PTS Diagnostics CardioChek Plus Professional Analyzer, New analyzer, boxed, with carrying case, R...
FDA Device Recall #Z-0832-2020 — Class II — December 2, 2019
Recall Summary
| Recall Number | Z-0832-2020 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 2, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Polymer Technology Systems, Inc. |
| Location | Indianapolis, IN |
| Product Type | Devices |
| Quantity | 44,448 total |
Product Description
PTS Diagnostics CardioChek Plus Professional Analyzer, New analyzer, boxed, with carrying case, Reference Numbers 2700
Reason for Recall
One brand of batteries have a small dimensional difference in the negative button terminal, which, when the batteries are inserted incorrectly, can create the possibility for the battery terminals to make reverse contact. This reverse contact can cause a potential for overheating.
Distribution Pattern
The products were distributed US Nationwide. The products were distributed to the following foreign countries: Australia, Austria, Belgium, Bermuda, Canada, China, Chile, Costa Rica, Cayman Islands, Czech Republic, England, Finland, France, Germany, Greece, Hong Kong, India, Iraq, Italy, Jordan, Lebanon, Lithuania, Mexico, Morocco, Panama, Philippines, Poland, Qatar, Romania, Saudi Arabia, South Africa, South Korea, Spain, Sweden, Switzerland, Trinidad, UAE.
Lot / Code Information
All Serial Numbers shipped during the 11/1/2016 to 10/25/2019 timeframe. UDI: 00381932700016
Other Recalls from Polymer Technology Systems, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1438-2020 | Class II | PTS Detect Cotinine, Ref. No. 3061, UPC 3819330... | Jan 21, 2020 |
| Z-0833-2020 | Class II | PTS Diagnostics CardioChek Plus Professional An... | Dec 2, 2019 |
| Z-0834-2020 | Class II | Henry Schein CardioChek Starter Kit, Reference ... | Dec 2, 2019 |
| Z-0835-2020 | Class II | Henry Schein CardioChek Plus Professional Analy... | Dec 2, 2019 |
| Z-2158-2019 | Class III | Henry Schein Panels Lipid Panel test strip: I... | Jun 7, 2019 |
Frequently Asked Questions
Contact your physician immediately if you use an electrical device or implant affected by this recall. For external devices (monitors, pumps), stop using the device and contact the manufacturer for a replacement. For implanted devices (pacemakers, ICDs), your cardiologist will assess whether you need device replacement surgery — the decision depends on how dependent you are on the device and the actual failure rate observed in the field. Do not attempt to repair or modify a recalled electrical medical device yourself. Monitor for any new or unusual symptoms and report them to your doctor.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.